ICU mortality similar for patients with hematologic CA ± chemo

May 26, 2018

(HealthDay)—Short-term mortality is similar among patients with hematologic cancer who receive chemotherapy while in the intensive care unit (ICU) versus those who do not, according to a study published online May 4 in Cancer.

Stephen M. Pastores, M.D., from the Memorial Sloan-Kettering Cancer Center in New York City, and colleagues retrospectively reviewed the outcomes of 181 patients with who received in the ICU at a single center versus a matched cohort of ICU patients who did not receive chemotherapy.

The researchers found that the ICU and hospital mortality rates were 25 and 42 percent, respectively, for , compared to 22 and 33 percent, respectively, for non-chemotherapy patients. Patients who did receive chemotherapy had a significantly longer length of stay in the ICU (median, six versus three days; P < 0.001) and in the hospital (median, 22 versus 14 days; P = 0.024), compared with patients not receiving chemotherapy. There was a trend toward a higher risk of dying by 12 months among patients receiving chemotherapy in the ICU versus those who did not (hazard ratio, 1.45; P < 0.08).

"Short‐term mortality was similar among patients with hematologic malignancies who did and did not receive chemotherapy in the ICU, although patients who received chemotherapy had increased resource utilization," the authors write. "These results may inform ICU triage and goals-of-care discussions with patients and their families regarding outcomes after receiving chemotherapy in the ICU."

Explore further: Private insurance coverage of infused chemo varies by setting

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

Private insurance coverage of infused chemo varies by setting

February 23, 2018
(HealthDay)—From 2004 to 2014, there was an increase in the provision of infused chemotherapy in hospital outpatient departments (HOPDs), which is associated with increased spending, according to a research letter published ...

Small-cell lung cancer patients face barriers to receiving standard-of-care treatment

January 4, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...

Optimal timing ID'd for flu shot during three-week chemo cycle

December 28, 2016
(HealthDay)—For adults with solid cancer undergoing three-week cytotoxic chemotherapy cycles, antibody responses are comparable for influenza vaccination on day one and 11, according to a study published online Dec. 20 ...

Cystectomy plus chemo ups survival in bladder cancer

January 21, 2016
(HealthDay)—For patients with locally advanced bladder cancer, cystectomy plus adjuvant chemotherapy is associated with improved survival versus cystectomy alone, according to a study published online Jan. 19 in the Journal ...

Disparities seen in gastric cancer patients' receipt of pre-op chemo

February 13, 2018
(HealthDay)—Racial and ethnic disparities in the use of preoperative chemotherapy exist among patients with gastric cancer in the United States, according to a study published online Feb. 2 in Cancer.

70-gene signature impacts treatment decisions in breast CA

October 29, 2017
(HealthDay)—The 70-gene signature (GS) assay affects treatment decisions among physicians treating patients identified as being at intermediate risk with the 21-gene assay (21-GA), according to a study published online ...

Recommended for you

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.